Now Reading
J&J Seeks Emergency Use Nod for Covid Vaccine in India

J&J Seeks Emergency Use Nod for Covid Vaccine in India

Johnson & Johnson has sought approval from the Indian government for the emergency use of its single-shot vaccine. The company had said earlier on Monday that it is committed to bringing its single-dose Covid vaccine to India and looks forward to the ongoing discussions with the Indian government in this regard.

A company spokesperson said in a statement, “Johnson & Johnson Pvt Ltd applied for the EUA of its single-dose Covid-19 vaccine with the Government of India on August 5, 2021.” The statement said that this is an important milestone that the company’s tie-up with Biologicals E Ltd gives the people of India and the rest of the world a single-dose option of the Covid vaccine.

At the same time, recently the Ministry of Health also made a statement regarding Johnson & Johnson’s vaccine. NITI Aayog Health Member Dr VK Paul had told that Johnson & Johnson’s vaccine is produced outside. According to the plan of the Government of India, this vaccine will also be produced in Bio-E, Hyderabad.

“Biologicals E will be an important part of our global supply chain network, which will help support our Johnson & Johnson COVID-19 vaccine supply,” the statement said. After getting the approval of this single-dose vaccine, it will be easy to completely vaccinate more people in a short time. And Moderna’s vaccine is included. If Johnson & Johnson is approved, it will be the fourth vaccine in India. However, this will be the first single-shot vaccine in India.

According to the data of the Union Ministry of Health and Family Welfare, 49 crore 53 lakh 27 thousand 595 doses of Corona Vaccine have been given in the country so far (August 6, till 7 am). So far 38 crore 56 lakh 31 thousand 50 first doses of vaccine have been administered, while 10 crore 96 lakh 96 thousand 545 people have got both doses of the vaccine.

Indo Thai News Co. Ltd. © 2024  All Rights Reserved.

Scroll To Top